(Q42513368)

1 November 2017

Interaction of epithelial biomarkers, local immune response and condom use in cervical intraepithelial neoplasia 2-3 regression (English)

1 reference

cervical intraepithelial neoplasia

1 November 2017

0 references

local immune response

1 reference

based on heuristic

inferred from title

1 reference

1 reference

Johannes Pieter Albert Baak

10

object named as

Jan P A Baak

1 reference

1 November 2017

8

Ivar Skaland

1 reference

1 November 2017

9

Emiel A M Janssen

1 reference

1 November 2017

2

Einar Gudlaugsson

1 reference

1 November 2017

1

Ane Cecilie Munk

1 reference

1 November 2017

7

Arnold-Jan Kruse

1 reference

1 November 2017

5

Bent Fiane

1 reference

1 November 2017

Bianca van Diermen-Hidle

6

object named as

Bianca van Diermen Hidle

1 reference

1 November 2017

Irene Tveiteras Ovestad

3

1 reference

1 November 2017

Kjell Lovslett

4

1 reference

1 November 2017

language of work or name

English

0 references

publication date

24 September 2012

1 reference

1 November 2017

1 reference

1 November 2017

127

1 reference

1 November 2017

3

1 reference

1 November 2017

489-494

1 reference

Distribution of human papillomavirus genotypes in cervical intraepithelial neoplasia and invasive cervical cancer in Canada

1 November 2017

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2012.09.010

Human papillomavirus is a necessary cause of invasive cervical cancer worldwide

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2012.09.010

Dynamic behavioural interpretation of cervical intraepithelial neoplasia with molecular biomarkers

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2012.09.010

Local immune response in the microenvironment of CIN2-3 with and without spontaneous regression.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2012.09.010

Natural history of cervical neoplasia and risk of invasive cancer in women with cervical intraepithelial neoplasia 3: a retrospective cohort study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2012.09.010

Spontaneous regression of high-grade cervical dysplasia: effects of human papillomavirus type and HLA phenotype

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2012.09.010

Frequency of cervical intraepithelial neoplasia treatment in a well-screened population

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2012.09.010

Obstetric outcomes after conservative treatment for intraepithelial or early invasive cervical lesions: systematic review and meta-analysis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2012.09.010

Pregnancy outcome in women before and after cervical conisation: population based cohort study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2012.09.010

Cervical intraepithelial neoplasia grade 3 lesions can regress

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2012.09.010

The E6 oncoprotein encoded by human papillomavirus types 16 and 18 promotes the degradation of p53

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2012.09.010

The human papilloma virus-16 E7 oncoprotein is able to bind to the retinoblastoma gene product

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2012.09.010

The presence of high-risk HPV combined with specific p53 and p16INK4a expression patterns points to high-risk HPV as the main causative agent for adenocarcinoma in situ and adenocarcinoma of the cervix

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2012.09.010

Significance of p53-binding protein 1 nuclear foci in uterine cervical lesions: endogenous DNA double strand breaks and genomic instability during carcinogenesis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2012.09.010

Analysis of FOXP3 protein expression in human CD4+CD25+ regulatory T cells at the single-cell level

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2012.09.010

The multi-subunit interleukin-2 receptor

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2012.09.010

The impact of epithelial biomarkers, local immune response and human papillomavirus genotype in the regression of cervical intraepithelial neoplasia grades 2-3

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2012.09.010

Natural history of dysplasia of the uterine cervix

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2012.09.010

Condom use promotes regression of cervical intraepithelial neoplasia and clearance of human papillomavirus: a randomized clinical trial

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2012.09.010

Receiver-operating characteristic curve analysis in diagnostic, prognostic and predictive biomarker research

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2012.09.010

Interval cervical cancer following treatment for cervical intraepithelial neoplasia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2012.09.010

The effect of condom use on squamous cell cervical intraepithelial neoplasia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2012.09.010

Evolving immunosuppressive microenvironment during human cervical carcinogenesis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2012.09.010

High-risk human papillomavirus E7 expression reduces cell-surface MHC class I molecules and increases susceptibility to natural killer cells.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2012.09.010

Paradoxical roles of the immune system during cancer development

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2012.09.010

Prospective follow-up of cervical HPV infections: life table analysis of histopathological, cytological and colposcopic data

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2012.09.010

Prospective evaluation of the Hybrid Capture 2 and AMPLICOR human papillomavirus (HPV) tests for detection of 13 high-risk HPV genotypes in atypical squamous cells of uncertain significance

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2012.09.010

Agreement between the AMPLICOR Human Papillomavirus Test and the Hybrid Capture 2 assay in detection of high-risk human papillomavirus and diagnosis of biopsy-confirmed high-grade cervical disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2012.09.010

Comparison of different commercial methods for HPV detection in follow-up cytology after ASCUS/LSIL, prediction of CIN2-3 in follow up biopsies and spontaneous regression of CIN2-3

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2012.09.010

HPV genotypes in high grade cervical lesions and invasive cervical carcinoma as detected by two commercial DNA assays, North Carolina, 2001-2006

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2012.09.010

10.1016/J.YGYNO.2012.09.010

7 January 2021

Identifiers

DOI

1 reference

1 November 2017

1 reference